Get startedLog in
    Picture of Dermata Therapeutics logo

    DRMA — Dermata Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    All News

    Brief: Dermata Therapeutics Received Gross Proceeds Of $5.0 Million In April 2022

    Picture of Dermata Therapeutics logoDermata Therapeutics
    16/05/2022 22:41
    May 16 (Reuters) - Dermata Therapeutics Inc  DRMA.O :
    * DERMATA THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.33
    * DERMATA THERAPEUTICS- RECEIVED GROSS PROCEEDS OF $5.0
MILLION IN
APRIL 2022 TOGETHER WITH EXISTING CASH RESOURCES,  EXPECTED TO
FUND OPERATIONS INTO Q2 OF 2023

Source text for Eikon: [https://bit.ly/3lhvPUZ]
Further company coverage:  DRMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Dermata Therapeutics

    See all news